Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Total 13F shares
-
27,567,001
-
Share change
-
+2,369,989
-
Total reported value
-
$2,693,889,000
-
Put/Call ratio
-
198%
-
Price per share
-
$97.72
-
Number of holders
-
93
-
Value change
-
+$229,200,158
-
Number of buys
-
54
-
Number of sells
-
37
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q4 2017
As of 31 Dec 2017,
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,567,001 shares.
The largest 10 holders included
FMR LLC, Hillhouse Capital Management, Ltd., BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, Temasek Holdings (Private) Ltd, ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, OppenheimerFunds, Inc., CANADA PENSION PLAN INVESTMENT BOARD, and Boxer Capital, LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.